1. Home
  2. Analysis
  3. Proair-hfa
  4. Neoplasm-progression

Proair hfa and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is reported as a side effect among people who take Proair hfa (albuterol sulfate), especially for people who are female, 60+ old, also take Ibrance, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Neoplasm progression when taking Proair hfa. It is created by eHealthMe based on reports of 52,628 people who have side effects when taking Proair hfa from the FDA, and is updated regularly.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 53,227 Proair hfa users. Check the latest studies of Proair hfa.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,067 drugs and 915 conditions by eHealthMe. Check the latest studies of Neoplasm progression.

On Aug, 04, 2026

52,628 people reported to have side effects when taking Proair hfa.
Among them, 56 people (0.11%) have Neoplasm progression.

Could Proair hfa cause Neoplasm progression?

Among these 56 people:

What is the gender of people who have Neoplasm progression when taking Proair hfa? *

  • female: 83.93 %
  • male: 16.07 %

What is the age of people who have Neoplasm progression when taking Proair hfa? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 5 %
  • 60+: 95 %

What are other drugs people take besides Proair hfa? *

  1. Ibrance: 23 people, 41.07%
  2. Lasix: 18 people, 32.14%
  3. Meloxicam: 17 people, 30.36%
  4. Cymbalta: 16 people, 28.57%
  5. Zometa: 16 people, 28.57%
  6. Zyrtec: 15 people, 26.79%
  7. Morphine: 15 people, 26.79%
  8. Fosamax: 15 people, 26.79%
  9. Norco: 15 people, 26.79%
  10. Dilaudid: 15 people, 26.79%

What are other side effects people have besides Neoplasm progression? *

  1. Back Pain: 17 people, 30.36%
  2. Fatigue (feeling of tiredness): 16 people, 28.57%
  3. Pain: 16 people, 28.57%
  4. Pneumonia: 15 people, 26.79%
  5. Depression: 15 people, 26.79%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 25.00%
  7. Fall: 14 people, 25.00%
  8. Pain In Extremity: 14 people, 25.00%
  9. Rashes (redness): 14 people, 25.00%
  10. Abdominal Pain: 13 people, 23.21%

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 21 people, 37.50%
  2. Hypersensitivity: 16 people, 28.57%
  3. Metastatic Neoplasm (spreadable cancer tumour): 12 people, 21.43%
  4. Breast Cancer Female: 12 people, 21.43%
  5. Diabetes: 11 people, 19.64%
  6. Pain: 9 people, 16.07%
  7. Breast Cancer: 5 people, 8.93%
  8. Thyroid Diseases: 4 people, 7.14%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 7.14%
  10. Bone Disorder: 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Proair hfa and have Neoplasm progression?

- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Proair hfa:

Neoplasm progression treatments and more:

How severe was Neoplasm progression and when was it recovered:

Expand to all the drugs that have ingredients of albuterol sulfate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm progression:

Browse all the conditions that are associated with Neoplasm progression:

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate (the active ingredients of Proair hfa) and Proair hfa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.